Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Clin Pharmacol Ther. 2008 Jul 2;84(3):332–339. doi: 10.1038/clpt.2008.101

Table 2.

Dosing algorithm for Caucasians in the multivariate linear regression model (outcome variable is log warfarin maintenance dose per day).*

Variable N Regression coefficient
(95% CI)
Intercept 147 2.74 (2.38 to 3.10)
Age 147 −0.01 (−0.01 to 0.00)
VKORC1 1173 (CT=1) 74 −0.40 (−0.53 to −0.27)
VKORC1 1173 (TT=1) 13 −0.82 (−1.05 to −0.59)
CYP2C9 (any*2=1) 42 −0.21 (−0.36 to −0.07)
CYP2C9 (any*3=1) 18 −0.32 (−0.52 to −0.12)
BMI (less than 25=1) 50 −0.18 (−0.35 to −0.01)
BMI (25 to 30=1) 59 −0.19 (−0.35 to −0.03)
Number of medications that potentiate warfarin 147 −0.08 (−0.14 to −0.03)
Most drinks on one occasion 147 0.03 (0.00 to 0.05)
History of deep vein thrombosis (yes=1) 16 0.21 (0.01 to 0.41)
Gender (female=1) 43 −0.13 (−0.27 to 0.02)
*

Dose (mg/day) = exp[2.74 −(0.01 X age) −(0.40 X VKORC1 1173CT) −(0.82 X VKORC1 1173TT) −(0.21 X CYP2C9 any*2) −(0.32 X CYP2C9 any*3) −(0.18 X BMI <25) −(0.19 X BMI 25 to 30) −(0.08 X number of medications that potentiate warfarin) +(0.03 X most alcoholic drinks on one occasion) +(0.21 X history of deep vein thrombosis) −(0.13 X female)]

Age, number of medications that potentiate warfarin, and most drinks on one occasion were entered as linear terms in the model and dummy variables (0=absent, 1=present) for the other variables.